Management of Crohn's disease in adults
- PMID: 19174807
- DOI: 10.1038/ajg.2008.168
Management of Crohn's disease in adults
Abstract
Guidelines for clinical practice are intended to suggest preferable approaches to particular medical problems as established by interpretation and collation of scientifically valid research, derived from extensive review of published literature. When data that will withstand objective scrutiny are not available, a recommendation may be made based on a consensus of experts. Guidelines are intended to apply to the clinical situation for all physicians without regard to specialty. Guidelines are intended to be flexible, not necessarily indicating the only acceptable approach, and should be distinguished from standards of care that are inflexible and rarely violated. Given the wide range of choices in any health-care problem, the physician should select the course best suited to the individual patient and the clinical situation presented. These guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee. Expert opinion is solicited from the outset for the document. The quality of evidence upon which a specific recommendation is based is as follows: Grade A: Homogeneous evidence from multiple well-designed randomized (therapeutic) or cohort (descriptive) controlled trials, each involving a number of participants to be of sufficient statistical power. Grade B: Evidence from at least one large well-designed clinical trial with or without randomization, from cohort or case-control analytic studies, or well-designed meta-analysis. Grade C: Evidence based on clinical experience, descriptive studies, or reports of expert committees. The Committee reviews guidelines in depth, with participation from experienced clinicians and others in related fields. The final recommendations are based on the data available at the time of the production of the document and may be updated with pertinent scientific developments at a later time.
Similar articles
-
Management of Crohn's disease in adults.Am J Gastroenterol. 1997 Apr;92(4):559-66. Am J Gastroenterol. 1997. PMID: 9128300 Review.
-
Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee.Am J Gastroenterol. 1997 Jul;92(7):1081-91. Am J Gastroenterol. 1997. PMID: 9219775 Review.
-
Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology.Am J Gastroenterol. 1997 Nov;92(11):1962-75. Am J Gastroenterol. 1997. PMID: 9362174 Review.
-
Practice guidelines in acute pancreatitis.Am J Gastroenterol. 1997 Mar;92(3):377-86. Am J Gastroenterol. 1997. PMID: 9068455
-
Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee.Am J Gastroenterol. 1997 May;92(5):739-50. Am J Gastroenterol. 1997. PMID: 9149180 Review.
Cited by
-
Tools for primary care management of inflammatory bowel disease: do they exist?World J Gastroenterol. 2015 Apr 21;21(15):4457-65. doi: 10.3748/wjg.v21.i15.4457. World J Gastroenterol. 2015. PMID: 25914455 Free PMC article. Review.
-
Effectiveness and risk associated with infliximab alone and in combination with immunosuppressors for Crohn's disease: a systematic review and meta-analysis.Int J Clin Exp Med. 2015 Apr 15;8(4):4846-54. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26131059 Free PMC article.
-
Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.World J Gastroenterol. 2015 Jan 7;21(1):21-46. doi: 10.3748/wjg.v21.i1.21. World J Gastroenterol. 2015. PMID: 25574078 Free PMC article. Review.
-
The Role of Probiotics in Inducing and Maintaining Remission in Crohn's Disease and Ulcerative Colitis: A Systematic Review of the Literature.Biomedicines. 2023 Feb 8;11(2):494. doi: 10.3390/biomedicines11020494. Biomedicines. 2023. PMID: 36831029 Free PMC article. Review.
-
Relapse-Free Course in Nearly Half of Crohn's Disease Patients With Infliximab and Plant-Based Diet as First-Line Therapy: A Single-Group Trial.Perm J. 2022 Jun 29;26(2):40-53. doi: 10.7812/TPP/21.073. Epub 2022 Jun 15. Perm J. 2022. PMID: 35933676 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical